ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management

JACC Guideline Comparison

Maninder Singh, Zachary A. Sporn, Hartzell V Schaff, Patricia Pellikka

Research output: Contribution to journalReview article

Abstract

Prosthetic heart valve interventions continue to evolve with new innovations in surgical and transcatheter technologies. We compared the recommendations from the 2017 American College of Cardiology/American Heart Association guidelines for management of patients with prosthetic heart valves with the 2017 European Society of Cardiology guidelines. The 2 documents differed regarding recommendations for follow-up imaging, the choice of biological versus mechanical prosthesis, bridging therapies, role of aspirin, use of fibrinolytic therapy for prosthetic valve thrombosis, and management of paravalvular regurgitation. This review highlights the differences between the 2 guidelines, summarizes new evidence, and offers recommendations for the management of patients with prosthetic heart valves in these areas of controversy.

Original languageEnglish (US)
Pages (from-to)1707-1718
Number of pages12
JournalJournal of the American College of Cardiology
Volume73
Issue number13
DOIs
StatePublished - Apr 9 2019

Fingerprint

Heart Valves
Guidelines
Thrombolytic Therapy
Aspirin
Prostheses and Implants
Thrombosis
Technology
Therapeutics

Keywords

  • comparison
  • guidelines
  • imaging
  • prosthetic heart valves
  • valvular heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management : JACC Guideline Comparison. / Singh, Maninder; Sporn, Zachary A.; Schaff, Hartzell V; Pellikka, Patricia.

In: Journal of the American College of Cardiology, Vol. 73, No. 13, 09.04.2019, p. 1707-1718.

Research output: Contribution to journalReview article

@article{e157b1f13ad1412686f0fef7c32fa82b,
title = "ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison",
abstract = "Prosthetic heart valve interventions continue to evolve with new innovations in surgical and transcatheter technologies. We compared the recommendations from the 2017 American College of Cardiology/American Heart Association guidelines for management of patients with prosthetic heart valves with the 2017 European Society of Cardiology guidelines. The 2 documents differed regarding recommendations for follow-up imaging, the choice of biological versus mechanical prosthesis, bridging therapies, role of aspirin, use of fibrinolytic therapy for prosthetic valve thrombosis, and management of paravalvular regurgitation. This review highlights the differences between the 2 guidelines, summarizes new evidence, and offers recommendations for the management of patients with prosthetic heart valves in these areas of controversy.",
keywords = "comparison, guidelines, imaging, prosthetic heart valves, valvular heart disease",
author = "Maninder Singh and Sporn, {Zachary A.} and Schaff, {Hartzell V} and Patricia Pellikka",
year = "2019",
month = "4",
day = "9",
doi = "10.1016/j.jacc.2019.01.038",
language = "English (US)",
volume = "73",
pages = "1707--1718",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "13",

}

TY - JOUR

T1 - ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management

T2 - JACC Guideline Comparison

AU - Singh, Maninder

AU - Sporn, Zachary A.

AU - Schaff, Hartzell V

AU - Pellikka, Patricia

PY - 2019/4/9

Y1 - 2019/4/9

N2 - Prosthetic heart valve interventions continue to evolve with new innovations in surgical and transcatheter technologies. We compared the recommendations from the 2017 American College of Cardiology/American Heart Association guidelines for management of patients with prosthetic heart valves with the 2017 European Society of Cardiology guidelines. The 2 documents differed regarding recommendations for follow-up imaging, the choice of biological versus mechanical prosthesis, bridging therapies, role of aspirin, use of fibrinolytic therapy for prosthetic valve thrombosis, and management of paravalvular regurgitation. This review highlights the differences between the 2 guidelines, summarizes new evidence, and offers recommendations for the management of patients with prosthetic heart valves in these areas of controversy.

AB - Prosthetic heart valve interventions continue to evolve with new innovations in surgical and transcatheter technologies. We compared the recommendations from the 2017 American College of Cardiology/American Heart Association guidelines for management of patients with prosthetic heart valves with the 2017 European Society of Cardiology guidelines. The 2 documents differed regarding recommendations for follow-up imaging, the choice of biological versus mechanical prosthesis, bridging therapies, role of aspirin, use of fibrinolytic therapy for prosthetic valve thrombosis, and management of paravalvular regurgitation. This review highlights the differences between the 2 guidelines, summarizes new evidence, and offers recommendations for the management of patients with prosthetic heart valves in these areas of controversy.

KW - comparison

KW - guidelines

KW - imaging

KW - prosthetic heart valves

KW - valvular heart disease

UR - http://www.scopus.com/inward/record.url?scp=85063250620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063250620&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.01.038

DO - 10.1016/j.jacc.2019.01.038

M3 - Review article

VL - 73

SP - 1707

EP - 1718

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 13

ER -